# OnCo record roy-herbst (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/roy-herbst/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "roy-herbst" ;
  schema:name "Roy S. Herbst"@en ;
  schema:description "Lung cancer trialist behind KEYNOTE-010 and the ADAURA adjuvant osimertinib trial."@en ;
  schema:url <https://onco.cc/people/roy-herbst/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Roy_S._Herbst> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Herbst%20RS%5BAuthor%5D%20lung%20pembrolizumab%20OR%20osimertinib> ;
  onco:tag "lung", "immunotherapy", "adjuvant" ;
  schema:jobTitle "Deputy Director and Chief of Medical Oncology, Yale Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/atezolizumab/> ;
  onco:institutions <https://onco.cc/institutions/yale-cancer-center/>, <https://onco.cc/institutions/dartmouth-cancer-center/> ;
  onco:trials <https://onco.cc/trials/adaura/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-adaura-nejm-2020/> ;
  schema:affiliation <https://onco.cc/institutions/yale-cancer-center/> .